Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Impact of <i>KRAS</i> Mutations on Clinical Outcomes in Pancreatic Cancer Patients Treated with First-line Gemcitabine-Based Chemotherapy2011 · 145 citations
2. 2Phase 1 trial of gemcitabine/nab-paclitaxel in combination with the autophagy inhibitor hydroxychloroquine in previously untreated patients with metastatic pancreatic adenocarcinoma.2015 · 8 citations
3. 3Phase II trial of the autophagy inhibitor hydroxychloroquine with FOLFOX and bevacizumab in front line treatment of metastatic colorectal cancer.2017 · 27 citations
4. 4Chloroquine reduces hypercoagulability in pancreatic cancer through inhibition of neutrophil extracellular traps2018 · 163 citations
5. 5New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)2008 · 29,635 citations